anti-CD5 Molecule (CD5) Antibodies

May act as a receptor in regulating T-cell proliferation.. Additionally we are shipping CD5 Proteins (23) and CD5 Kits (20) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
CD5 12507 P13379
CD5 921 P06127
CD5 54236 P51882
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-CD5 Antibodies at antibodies-online.com

Showing 10 out of 1287 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated WB WB Suggested Anti-CD5 Antibody Titration: 0.2-1 ug/mlELISA Titer: 1:312500Positive Control: COLO205 cell lysate WB Suggested Anti-CD5  Antibody Titration: 0.2-1 µg/mL ELISA Titer: 1:.12500  Positive Control: COLO205 cell lysate 100 μL Log in to see 2 to 3 Days
$289.00
Details
Mouse Rat Biotin FACS   0.1 mg Log in to see 15 to 18 Days
$160.60
Details
Mouse Rat PE Func, FACS, IHC (fro), IP, WB 0.1 mg Log in to see 6 to 8 Days
$324.50
Details
Mouse Rat Un-conjugated BR, CyTox, IHC (f), IHC (fro), FACS, IP, ELISA   0.5 mg Log in to see 15 to 18 Days
$262.95
Details
Human Mouse Un-conjugated ELISA, FACS, WB Black line: Control Antigen (100 ng);Purple line: Antigen(10ng);Blue line: Antigen (50 ng);Red line: Antigen (100 ng); Dilution: 1/10000 Figure 1: Western blot analysis using CD5 mAb against human CD5 recombinant protein. (Expected MW is 48.3 kDa) Dilution: 1/250 100 μL Log in to see 8 to 11 Days
$577.50
Details
Mouse Rat FITC Func, FACS, IHC (fro), IP, WB   0.1 mg Log in to see 6 to 8 Days
$225.50
Details
Mouse Rat Biotin Func, FACS, IHC (fro), IP, WB   0.5 mg Log in to see 6 to 8 Days
$445.50
Details
Mouse Rat APC Func, FACS, IHC (fro), IP, WB   0.1 mg Log in to see 6 to 8 Days
$522.50
Details
Human Mouse Un-conjugated FACS, IHC (fro), IP, WB 0.1 mg Log in to see 6 to 8 Days
$258.50
Details
Mouse Rat Un-conjugated Func, FACS, IHC (fro), IP, WB   0.5 mg Log in to see 6 to 8 Days
$368.50
Details

Top referenced anti-CD5 Antibodies

  1. Mouse (Murine) Monoclonal CD5 Primary Antibody for BR, CyTox - ABIN2689320 : Azzam, Grinberg, Lui, Shen, Shores, Love: CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. in The Journal of experimental medicine 1999 (PubMed)
    Show all 18 Pubmed References

  2. Mouse (Murine) Monoclonal CD5 Primary Antibody for FACS - ABIN2689322 : Bendelac, Rivera, Park, Roark: Mouse CD1-specific NK1 T cells: development, specificity, and function. in Annual review of immunology 1997 (PubMed)
    Show all 18 Pubmed References

  3. Human Monoclonal CD5 Primary Antibody for ICC, FACS - ABIN1111110 : Dunphy, Tang: The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases. in Archives of pathology & laboratory medicine 2007 (PubMed)
    Show all 5 Pubmed References

  4. Human Monoclonal CD5 Primary Antibody for ICC, FACS - ABIN1111108 : Gong, Lagoo, Peters, Horvatinovich, Benz, Buckley: Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma. in American journal of clinical pathology 2001 (PubMed)
    Show all 5 Pubmed References

  5. Human Monoclonal CD5 Primary Antibody for ICC, FACS - ABIN1043027 : McAlister, Davis, Pfuhl, Driscoll: NMR analysis of the N-terminal SRCR domain of human CD5: engineering of a glycoprotein for superior characteristics in NMR experiments. in Protein engineering 1999 (PubMed)
    Show all 5 Pubmed References

  6. Human Monoclonal CD5 Primary Antibody for ICC, FACS - ABIN1981853 : Shuster, Falletta, Pullen, Crist, Humphrey, Dowell, Wharam, Borowitz: Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. in Blood 1990 (PubMed)
    Show all 5 Pubmed References

  7. Human Monoclonal CD5 Primary Antibody for ICC, FACS - ABIN2749130 : Engleman, Warnke, Fox, Dilley, Benike, Levy: Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. in Proceedings of the National Academy of Sciences of the United States of America 1981 (PubMed)
    Show all 5 Pubmed References

  8. Human Monoclonal CD5 Primary Antibody for ELISA, FACS - ABIN125749 : Freedman, Freeman, Whitman, Segil, Daley, Levine, Nadler: Expression and regulation of CD5 on in vitro activated human B cells. in European journal of immunology 1989 (PubMed)
    Show all 5 Pubmed References

  9. Human Monoclonal CD5 Primary Antibody for ELISA, FACS - ABIN125750 : Raman: CD5, an important regulator of lymphocyte selection and immune tolerance. in Immunologic research 2002 (PubMed)
    Show all 5 Pubmed References

More Antibodies against CD5 Interaction Partners

Mouse (Murine) CD5 Molecule (CD5) interaction partners

  1. Binding studies show that both soluble and membrane-bound forms of CD5 and CD6 bind to intact viable protoscoleces from E. granulosus s.l. through recognition of metaperiodate-resistant tegumental components.

  2. The natural substrate for the cell surface sialidase was identified as clustered differentiation 5 (CD5) by PNA-blot analysis of anti-CD5 immunoprecipitate.

  3. FasL expression in splenic CD5(+)CD1d(hi) B cells was decreased compared to the control group after TLR4 ligation.

  4. CD5-CK2 signaling axis regulates positive selection by modulating activation of ERK and promoting survival independent of proximal TCR signals

  5. the reduction in the positive selection conferred by CD5 overexpression was unaffected by SHP-1 deficiency.

  6. In mice lacking functional KDELR1, surviving naive T cells expressed significantly higher levels of CD5, a surrogate marker of TCR self-reactivity.

  7. In mouse tumor models, CD5(+) but not CD5(-) B cells promoted tumor growth. The results demonstrate a critical role of CD5(+) B cells in promoting cancer.

  8. CD5 and CD72 play a critical role in maintaining regulatory T and B cell homeostasis

  9. CD5 promoted Treg cell induction in response to self and tolerizing antigens by blocking mTOR activation.

  10. Data indicate that CD5-casein kinase 2 (CK2) signaling is necessary for efficient nuclear localization of orphan nuclear receptor ROR-gammaT (RORgammat).

  11. These results support the notion that the distal cytoplasmic domain of CD5, including Y463, plays a relevant role in the downmodulation of TCR signals in thymocytes via c-Cbl.

  12. Although the percentage of CD1d(hi)CD5+ subset in splenic B cells does not change significantly, percent IL-10-expressing cells among total splenic B cells or the CD1dhiCD5+ population significantly increases 3-7 days after rCRT/39-272 administration

  13. Different CD5 expression levels influence the proliferation dynamics of activated naive CD4+ T cells while leaving the conversion rate of those cells into memory cells unaffected.

  14. Data show several homologies across human, rat and mouse in the kinetic of loss of several LAgs such as CD5, CD4 and CD28.

  15. CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase

  16. Delayed tumor growth in CD5-deficient mice is associated with enhanced activation of tumor-infiltrating lymphocytes due to an upregulated T cell response to T cell receptor (TCR) stimulation.

  17. A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells.

  18. Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient 'viable motheaten' mice.

  19. CD5, an important regulator of lymphocyte selection and immune tolerance. Review.

  20. CD5 is rapidly recruited at the immunological synapse (IS) and lowers the T cell response elicited by antigen presentation by targeting downstream signaling events without affecting IS formation.

Human CD5 Molecule (CD5) interaction partners

  1. the present results support the notion that CD5 is not only a phenotypic marker but a relevant player in CLL cell biology, as demonstrated by the influence of germline-defined functional CD5 variants on CLL outcome.

  2. ZAP70 is the only gene that is differentially expressed in CD5-high and CD5-low normal B-lymphocytes, confirming the key role of Zap-70 tyrosine kinase in BCR signaling alterations in B-CLL.

  3. The high CD5 plasma levels in patients with severe ASD, probably indicated that CD5 might be implicated in the physiology of autism. However, this finding should be treated with caution until further investigations are performed with larger populations to determine whether the increase in plasma CD5 levels is a mere consequence of autism or it plays a pathogenic role in the disease.

  4. A CD34-negative MYC-rearranged B-lymphoblastic lymphoma aberrantly expresses CD3 and CD5.

  5. study provides understanding of the regulation of CD5 expression on leukaemic T cells, and may help in understanding the molecular mechanism of CD5 down-regulation.

  6. CD5 transcription is increased, leading to the production of three mRNA isoforms by APA, all contributing for protein production, at different levels. PTBP1 binds in the vicinity of pA1, leading to an increase in mRNA levels and miR-204 targets the longer CD5 mRNA.

  7. High CD5 expression is associated with lymphoma in Waldeyer ring.

  8. Thus, trans-signaling of IL-6 can only occur via sIL-6R, but not sCD5.

  9. The major proportion of CD5(low) B cells in patients are leukemic, thus identifying CD5(low) B cells as an important component of CLL, with implications for CLL pathogenesis, clinical monitoring, and the development of anti-CD5-directed therapies.

  10. the CD5 Pro224-Ala471 haplotype in homozygosis improved melanoma survival in the entire set of patients (HR = 0.27, 95% CI 0.11-0.67, Adj. p = 0.005). These findings highlight the relevance of genetic variability in immune-related genes for clinical outcome in melanoma.

  11. R-EPOCH therapy does not seem to impact the known poorer prognosis of patients with de novo CD5+ diffuse large B-cell lymphoma , and CD5 expression was still an independent prognostic factor in R-EPOCH-treated patients with diffuse large B-cell lymphoma.

  12. CD5+B lymphocytes were increased and activated in autoimmune hemolytic anemia patients.

  13. This study confirms the poor prognosis of de novo CD5+ DLBCL in a large multi-center cohort despite initial rituximab-containing chemotherapy and suggests that stem cell transplantation fails to salvage the majority of these patients.

  14. 5.2 % were positive for CD5 and 5.7 % positive for epstein-Barr virus encoded RNA

  15. CD5 polymorphisms are associated with systemic lupus erythematosus.

  16. three tyrosine-based domains within CD5 cytoplasmic tail promote T-cell survival through non-overlapping mechanisms

  17. A case of mantle cell lymphoma with a unique pattern of CD5 negative to positive expression switching in relapse.

  18. useful in distinguishing thymic carcinoma from poorly differentiated lung carcinoma

  19. Data show that the proportion of CD5+ B cells at 1 mo of age is inversely correlated to total IgG levels at 18 and 36 mo of age.

  20. down-regulation of CD5 on activated CD8(+) T cells may serve as a useful marker of dysregulated T cell activation and proliferation in FHL2.

Cow (Bovine) CD5 Molecule (CD5) interaction partners

  1. Differential expression of CD5bright and CD5dim subpopulations on B cells in animals with paratuberculosis may reflect a shift in host immunity during the disease process.

Rabbit CD5 Molecule (CD5) interaction partners

  1. Findings suggest that development, selection and function of different B- and T-cell subsets may be directly or indirectly dependent on different glycan structures associated with CD5 or CD5-like molecules expressed on T cells compared to B cells.

CD5 Antigen Profile

Protein Summary

May act as a receptor in regulating T-cell proliferation.

Gene names and symbols associated with anti-CD5 Molecule (CD5) Antibodies

  • CD5 molecule (CD5) antibody
  • CD5 antigen (Cd5) antibody
  • CD5 molecule like (CD5L) antibody
  • Cd5 molecule (Cd5) antibody
  • CD5 antibody
  • LEU1 antibody
  • Ly-1 antibody
  • Ly-12 antibody
  • Ly-A antibody
  • Lyt-1 antibody
  • T1 antibody

Protein level used designations for anti-CD5 Molecule (CD5) Antibodies

CD5 molecule , t-cell surface glycoprotein CD5-like , T-cell surface glycoprotein CD5 , lymphocyte antigen 1 , CD5 antigen (p56-62) , lymphocyte antigen T1/Leu-1 , CD5 antigen , Lymphocyte antigen CD5 , CD74 antigen, invariant polypeptide of major , lymphocyte receptor CD5

GENE ID SPECIES
695249 Macaca mulatta
737721 Pan troglodytes
100446127 Pongo abelii
100590674 Nomascus leucogenys
12507 Mus musculus
100054450 Equus caballus
921 Homo sapiens
54236 Rattus norvegicus
101083293 Felis catus
395757 Gallus gallus
443328 Ovis aries
612338 Canis lupus familiaris
280745 Bos taurus
100008958 Oryctolagus cuniculus
100513336 Sus scrofa
Selected quality suppliers for anti-CD5 (CD5) Antibodies
Did you look for something else?